The bacterium that causes blackleg, Clostridium chauvoei, was detected by molecular methods on 30% of sampled cattle farms in southern Chile (95% CI: 21.6–40.0), while not a single farm in the study had a laboratory-confirmed diagnosis — a diagnostic gap the authors describe as the likely driver of persistent outbreaks in a region where clostridial vaccination is widespread.

The cross-sectional observational study, conducted in the Los Ríos (39°S 73°W) and Los Lagos (41°S 73°W) regions, is the first epidemiological investigation in Chile's southern macrozone to combine direct molecular detection of C. chauvoei in environmental matrices with a characterization of diagnostic and management practices on bovine farms. The two regions together hold roughly 55.7% of the national cattle population — Los Lagos 35.3% and Los Ríos 20.4% — making the findings relevant to the majority of Chile's beef and dairy output. The study covered commercial beef and dairy operations with at least 10 cattle and active production records, and was approved by the Universidad Austral de Chile (Approval No. 494/2023), conducted under ARRIVE guidelines. It was funded by ANID through FONDECYT Iniciación Project N° 11230617.

What the numbers show

The study's central finding is a three-way discrepancy: 51.0% of farms reported a clinical history consistent with blackleg, 30.0% showed confirmed pathogen presence by molecular detection, and 0% had any laboratory diagnostic confirmation. Previous reports of blackleg in the area rested mostly on clinical observation, the authors note, leaving the true disease burden unquantified until now.

Prevalence varied by production system and sample matrix. Beef farms carried a higher molecular prevalence (34.0%, 17/50; 95% CI: 21.9–48.2) than the overall figure, with dairy operations lower. A sample counted as positive when a species-specific target — cctA and/or nanA — was amplified, with genus- and species-level identity supported by 16S rRNA and fliC amplification respectively.

Why it matters at the herd level

Blackleg is an acute disease of cattle, and less frequently other ruminants, characterized by severe necrohemorrhagic myositis and high case-fatality. Under field conditions, presumptive diagnosis typically rests on lameness, crepitant swelling of muscle masses, sudden death, and gross pathology such as hemorrhagic and emphysematous myositis. Those signs overlap with other clostridial infections, including gas gangrene caused by Clostridium septicum. Definitive diagnosis requires anaerobic culture, fluorescent antibody testing, immunohistochemistry, or PCR — tools the study found essentially unused in the region.

The pathogenesis is endogenous: animals ingest spores from contaminated soil, which cross the intestinal mucosa, disseminate hematogenously to skeletal and cardiac muscle, and can remain latent within resident macrophages until local anaerobic conditions — often triggered by blunt trauma or exercise-induced hypoxia — precipitate germination and toxin production. Because spores persist in soil for extended periods, and environmental factors such as rainfall and soil disturbances have been linked to spore dispersion and outbreaks elsewhere, the authors suggest local environmental conditions may shape disease dynamics in southern Chile.

The region presents an epidemiological paradox the study set out to probe: outbreaks persist in supposedly vaccinated herds. One hypothesis is vaccine-strain mismatch; the alternative, which the genetic data support, is deficient diagnostic and management practice.

Genetic findings point away from vaccine failure

The researchers sequenced two virulence genes, cctA and nanA, chosen deliberately. CctA, toxin A, is a pore-forming leukotoxin responsible for hemolysis and cytolysis and — critically — is the primary protective antigen in commercial vaccines, so its sequence conservation bears directly on any vaccine-mismatch hypothesis. NanA, a neuraminidase also called sialidase, has validated reference datasets suitable for phylogenetic comparison. The characterization confirmed the evolutionary stability of local strains, consistent with the interpretation that persistence of the disease stems from diagnostic and management deficiencies rather than antigenic drift away from vaccine strains. Other virulence factors — hyaluronidase and alpha and beta toxins — fell outside the study's scope.

Implications by sector

For food-animal practitioners, the practical takeaway is that clinical suspicion of blackleg in this region carries substantial uncertainty: roughly half of farms report compatible clinical histories, but overlapping pathology with C. septicum and other clostridia means misclassification is likely without confirmatory testing. Molecular detection of C. chauvoei in soil and fecal samples, validated here as a workable surveillance approach, offers a route to risk assessment on endemic farms independent of clinical cases. Companion-animal medicine is essentially unaffected, as the disease targets cattle and other ruminants. Public-health exposure is limited — the study frames blackleg as an economic and livestock-health problem, driven by case-fatality and the cost of outbreak control and treatment, not as a zoonosis.

Notably, no published study has yet quantified losses or run cost-benefit analyses for clostridial disease control in Chile specifically, even though practitioners perceive a clear asymmetry between inexpensive vaccination protocols and the heavy cost of outbreak response — a gap the authors flag for future work.

The study, published by Elsevier in 2026, suggests the next steps for the region are straightforward: routine use of confirmatory diagnostics such as PCR or FAT on suspect cases, and environmental surveillance to map farm-level risk — measures that would clarify whether Chile's blackleg problem is truly one of vaccine failure or simply of not looking with the right tools.